Cargando…

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy

Parkinson’s disease (PD) and multiple system atrophy (MSA) belong to the neurodegenerative group of synucleinopathies; differential diagnosis between PD and MSA is difficult, especially at early stages, owing to their clinical and biological similarities. Thus, there is a pressing need to identify m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Do Hyeon, Hwang, Ji Su, Kim, Seok Gi, Jang, Yong Eun, Shin, Tae Hwan, Lee, Gwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836409/ https://www.ncbi.nlm.nih.gov/pubmed/35163800 http://dx.doi.org/10.3390/ijms23031879

Ejemplares similares

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
por: Kaiserova, Michaela, et al.
Publicado: (2021)

Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics
por: Hwang, Ji Su, et al.
Publicado: (2022)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis
por: Xie, Dan, et al.
Publicado: (2021)

Shearing of an intrathecal catheter during insertion for cerebrospinal fluid drainage
por: Lee, Jae Jun, et al.
Publicado: (2013)

Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic Profiles
por: Im, Ji Hye, et al.
Publicado: (2021)

Analysis of Nanotoxicity with Integrated Omics and Mechanobiology
por: Shin, Tae Hwan, et al.
Publicado: (2021)

The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients
por: Plewa, Szymon, et al.
Publicado: (2021)

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis
por: Židó, Michal, et al.
Publicado: (2023)

A Novel Implantable Cerebrospinal Fluid Reservoir : A Pilot Study
por: Byun, Yoon Hwan, et al.
Publicado: (2018)

Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy
por: Katayama, Takayuki, et al.
Publicado: (2021)

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
por: Kremer, Thomas, et al.
Publicado: (2021)

Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study
por: Židó, Michal, et al.
Publicado: (2022)

Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study
por: Stav, Ane Løvli, et al.
Publicado: (2016)

Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)

Intraventricular cerebrospinal fluid temperature analysis using MR diffusion-weighted imaging thermometry in Parkinson's disease patients, multiple system atrophy patients, and healthy subjects
por: Sumida, Kaoru, et al.
Publicado: (2015)

Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers
por: Montembeault, Maxime, et al.
Publicado: (2018)

Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases
por: Kwon, Ji-Woong, et al.
Publicado: (2022)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
por: Probert, Fay, et al.
Publicado: (2021)

The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics
por: Yang, Heng, et al.
Publicado: (2023)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
por: Foulds, P.G., et al.
Publicado: (2012)

Usefulness of Diffusion-Weighted MRI for Differentiation between Parkinson’s Disease and Parkinson Variant of Multiple System Atrophy
por: Chung, Eun Joo, et al.
Publicado: (2009)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
por: Freigang, Maren, et al.
Publicado: (2022)

Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy
por: Orbach, Rotem, et al.
Publicado: (2022)

Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy
por: Beaudin, Marie, et al.
Publicado: (2023)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Diesel-derived PM(2.5) induces impairment of cardiac movement followed by mitochondria dysfunction in cardiomyocytes
por: Shin, Tae Hwan, et al.
Publicado: (2022)

MBRS-56. RE-EVALUATION OF LEPTOMENINGEAL METASTASIS IN MEDULLOBLASTOMA WITH MAGNETIC RESONANCE IMAGING, RELATED SYMPTOMS AND CEREBROSPINAL FLUID METABOLOMIC PROFILES
por: Im, Ji Hye, et al.
Publicado: (2020)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab4pklrgpsc0ffqaebuf1sv4ku